Mazumdar-Shaw: Indian breweries refused to hire female brewmasters in late 1970s
Kiran Mazumdar-Shaw · Ep #7 | Who is Kiran Mazumdar Shaw Really? And WTF is Biotech? · Nikhil Kamath · Jul 23, 2023 · at 15:01
Biocon founder Kiran Mazumdar-Shaw discusses the gender discrimination she faced after returning to India as a certified brewmaster in the late 1970s.
0:00 / 0:41exact quote · 41.8s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Whilst breweries were very willing to help me, to ask me to come and help them fix their problems, do troubleshooting, which I did. I even commissioned a brewery in Calcutta. But when it came to giving me a job, I think no one wanted to risk that. They all said to me that this is a big risk. We've never, we don't even have a single woman in our leadership team. Ah, and we certainly don't think the brewmaster in charge of this brewery should be a woman, because we have hostile labor unions, we don't think you can deal with them, and we think it's, it just wouldn't be the right thing to do.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Kiran Mazumdar-Shaw
Mazumdar-Shaw: Vijay Mallya has paid back everything he owed
“Well, he's paid back everything he owed. So I don't understand why he's still being targeted.”
Mazumdar-Shaw: Biocon was the first startup in India
“Of course, a few years later, I was very lucky that I was able to get the brightest minds to join me, and I therefore consider myself really the first startup in the country.”
Mazumdar-Shaw: Entering biosimilars now would severely hurt Indian pharma earnings
“If any Indian pharmaceutical company wants to now venture into biosimilars, like I have done, it will, you know, have a huge impact on their EBITDA and their earnings, which I don't think anyone wants to do at this point in time.”
Mazumdar-Shaw: Regulations will permit CRISPR for genetic defects, not designer babies
“So I think they will allow you to use CRISPR technologies like they use gene therapies today. To basically correct genetic deficiencies, but not to choose the kind of baby you want, you know, like saying that, okay, I want my eyes, the eyes to be of this color…”
Mazumdar-Shaw: Going public creates valuation currency essential for scaling
“I believe that as you grow your company, you need you need a capital value for a kind of a currency that you use to grow your company with. So if you create a valuation for your company, you can use that as a very, very powerful currency to do many more things…”